Friday, February 04, 2022 10:22:01 AM
Many investors and flippers still seem to be watching the charts here at
$RMSL
vs diving deeper & actually looking at the potentially disruptive impact the 20 year patented DeltaWave mask can have on the sleep apnea market.
With just a 10% market penetration you are looking at $300-400MM/yr in revenue from just the mask. That is only at one mask per year. It is recommended to use 2-3 masks per year.
The soon to be FDA approved DeltaWave masks hits the key 14BPM which mimics the average natural, nighttime breathing rate. Most other masks from competitors come in generally between 6-8 which leads to the many issues and negative side effects for users.
This is not just a sleep apnea mask, it will also be the first and only mask that will be FDA approved to treat sleep apnea but also passes the baseline tests to treat COPD and congestive heart failure.
There is much to be excited about in the coming days, weeks, and months!!!
Recent RMSL News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/14/2024 01:10:38 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/14/2024 05:15:18 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 02/02/2024 09:58:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 09:38:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/22/2023 08:26:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 07:02:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 10:10:55 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:12:01 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/14/2023 01:58:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2023 07:21:17 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM